APA (7th ed.) Citation

M, S., S, F., G, T., B, V., & D, S. (2022). Long-term response to immuno-oncology after discontinuation for immuno-related pneumonia in metastatic renal carcinoma: A case report. Anti-cancer drugs, 33(1), 105. https://doi.org/10.1097/CAD.0000000000001134

Chicago Style (17th ed.) Citation

M, Stellato, Foderaro S, Tonini G, Vincenzi B, and Santini D. "Long-term Response to Immuno-oncology After Discontinuation for Immuno-related Pneumonia in Metastatic Renal Carcinoma: A Case Report." Anti-cancer Drugs 33, no. 1 (2022): 105. https://doi.org/10.1097/CAD.0000000000001134.

MLA (9th ed.) Citation

M, Stellato, et al. "Long-term Response to Immuno-oncology After Discontinuation for Immuno-related Pneumonia in Metastatic Renal Carcinoma: A Case Report." Anti-cancer Drugs, vol. 33, no. 1, 2022, p. 105, https://doi.org/10.1097/CAD.0000000000001134.